Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.
about
Systemic Treatment of Pediatric Psoriasis: A ReviewManaging Patients With Psoriasis in the Busy Clinic: Practical Tips for Health Care PractitionersNew and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitorsManaging patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasisTopical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea TreatmentsNanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue TargetingA patient-centred approach to biological treatment decision making for psoriasis: an expert consensusUnder-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan DataDiagnosis and management of psoriasis.Diagnostic et prise en charge du psoriasisThe Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.Economic impact of biologic utilization patterns in patients with psoriatic arthritisManagement of psoriasis in adolescence.Recommendations for a patient-centered approach to the assessment and treatment of scalp psoriasis: a consensus statement from the Asia Scalp Psoriasis Study Group.Apremilast.Adjuvant Narrow Band UVB Improves the Efficacy of Oral Azithromycin for the Treatment of Moderate to Severe Inflammatory Facial Acne Vulgaris.Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical settingQualifying unmet needs and improving standards of care in psoriatic arthritis.Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practiceDistribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis.Apremilast (Otezla): A New Oral Treatment for Adults With Psoriasis and Psoriatic Arthritis.Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis.A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in paTreatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial.Worldwide utilization of topical remedies in treatment of psoriasis: a systematic review.PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy.The adverse effects of the methoxsalen and ultraviolent A radiation on spermatogenesis in miceComparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis.Evolocumab lowers LDL-C safely and effectively when self-administered in the at-home settingApremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)The skin tissue is adversely affected by TNF-alpha blockers in patients with chronic inflammatory arthritis: a 5-year prospective analysis.Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world settingAn evolution in switching therapy for psoriasis patients who fail to meet treatment goals.Tolerability of Crisaborole Ointment for Application on Sensitive Skin Areas: A Randomized, Double-Blind, Vehicle-Controlled Study in Healthy Volunteers.A case series of the effects of a novel composition of a traditional natural preparation for the treatment of psoriasis.Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 Studies.Long-Term Cost-Effectiveness Analysis of Etanercept and Adalimumab for Plaque Psoriasis not Associated with Arthritis.Treatment sequencing after failure of the first biologic in cost-effectiveness models of psoriasis: a systematic review of published models and clinical practice guidelines.Evaluation of psoriasis patients' attitudes toward benefit-risk and therapeutic trade-offs in their choice of treatments.
P2860
Q26753026-AA802DA9-A4FE-4922-922F-882A7A7B5888Q26771785-7235D257-4E14-4304-ADA6-DA5DBB8403B7Q26800937-A627D0F7-1EB1-4FEA-886C-3437ED3318CAQ27693878-B8AB8C41-F08E-4189-BBBB-9D802F6CB69BQ28072685-F0C0273D-D704-420E-8008-B34CE107D48BQ28079462-4603083B-9D0A-4042-8495-1516CD7D0DECQ28082166-247025DD-FEBA-43F7-801C-09079387BF4DQ31146263-5CC83D6D-91AA-466E-AC22-B010B09A9F6CQ33558495-AC0BFAD9-16AD-419A-B9DE-B9F53CAA20E1Q33558550-255B1037-7349-43F1-9A82-498540305A46Q33572834-0763FCF4-237C-4789-AC43-DB2740928DFAQ33840422-FBF5F5E9-B92B-49A5-927C-633362F005F1Q34415058-70EC2E80-58F3-4D05-8CB0-93D83DD26458Q34452903-FD26C811-C765-4852-8349-22485868B737Q34612877-2134153D-D5FF-42BD-8108-8C149FDD1087Q34738374-F4EECC87-D5D7-4B24-A52C-93FFA0609C63Q34743112-517BF952-5305-402D-A13F-BB7370D15B83Q34803582-96A02AE0-B402-4C80-A0D5-707DC50A5211Q34997467-1087CC5C-E72C-4B15-8E3E-7CAB435EB47EQ35892185-B4383B67-D601-4D21-A5CF-A98706B6E321Q35896444-7AE1B60C-860C-4F66-8807-FD2A8CD44E13Q36052215-C24400AA-EAF9-477C-B5E6-A70F5A187132Q36085078-D3DBD6A1-4ED8-4542-9730-5FAB03C1E95DQ36157003-0F2D4956-BC56-411B-AFBD-20A478843D6EQ36175745-65E96BD2-EDD5-47B0-BB1F-AC51E05C8164Q36201382-3CD8EFD8-14E8-4E64-B8F4-D517BC5DC081Q36259977-108C560A-0B53-4D5F-A5AD-F8DA11DD20C5Q36334747-2E79B5CB-0191-4327-A563-946771AF37C0Q36417100-03249BD7-F4B1-427E-9461-3AB66ACFD3D8Q36665368-D9FA8336-2E25-44D9-8356-CD249C60D2FCQ36968787-FA773E1C-CF4B-4BD2-987D-985995E1B4D6Q37196596-3BCC5C01-BE56-4377-9157-E87F635128A6Q37221862-240735C4-5486-43D4-A289-0E20AAB7BDC1Q37295966-069446D3-9865-4E4F-B613-C4A01E714BF0Q37302054-FC7BAA3D-16A6-4BD1-B8E5-E7454C32E6F2Q37346037-45FC4E49-6A10-440C-A9F4-37A5A2B4DDEBQ37432244-E03A93FE-2D23-4A8F-980D-1A8291D5AFDAQ37468351-034FB74F-2E37-49C2-873F-E59C590EE451Q37660470-E98AA0E8-179D-4176-972D-9AA541621674Q37682855-A633C240-B712-4240-8AD4-9A8CE5E42D1A
P2860
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Guidelines of care for the man ...... nd evidence-based conclusions.
@en
Guidelines of care for the man ...... nd evidence-based conclusions.
@nl
type
label
Guidelines of care for the man ...... nd evidence-based conclusions.
@en
Guidelines of care for the man ...... nd evidence-based conclusions.
@nl
prefLabel
Guidelines of care for the man ...... nd evidence-based conclusions.
@en
Guidelines of care for the man ...... nd evidence-based conclusions.
@nl
P2093
P50
P1476
Guidelines of care for the man ...... and evidence-based conclusions
@en
P2093
Abby S Van Voorhees
Alan Menter
Alice Gottlieb
American Academy of Dermatology Work Group
Craig A Elmets
Craig L Leonardi
Henry W Lim
John Y M Koo
Karl R Beutner
Kenneth B Gordon
P304
P356
10.1016/J.JAAD.2010.11.055
P407
P577
2011-02-08T00:00:00Z